Company Search:
Advanced Search
Sponsored Links
GW Pharmaceuticals PLC- ADR Company Snapshot
GW Pharmaceuticals PLC- ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC- ADR with three other companies in this sector in the United States: Nascent Biotech Inc (2017 sales of $3.00 million ), Clinuvel Pharmaceuticals Limited ($12.84 million of which 100% was Biotechnology), and Aytu Bioscience Inc ($3.22 million ).

Sales Analysis. GW Pharmaceuticals PLC- ADR reported sales of $10.50 million for the fiscal year ending September of 2017. This represents a sharp decrease of 27.9% versus 2016, when the company's sales were $14.57 million.
  Stock Performance Chart for GW Pharmaceuticals PLC- ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): 130.21
(Figures in U.S. Dollars)
1 Week 5.5%   13 Weeks 12.4%  
4 Weeks 20.3%   52 Weeks 13.7%  
GW Pharmaceuticals PLC- ADR Key Data:
  Ticker: GWPH Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 10,502,379
(Year Ending Jan 2018).
Employees: 496
  Currency: U.S. Dollars Market Cap: 3,281,922,325
  Fiscal Yr Ends: September Shares Outstanding: 25,204,841
  Share Type: Common Closely Held Shares: 1,780,973
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.